Surgery Partners CS (SGRY-Q) Analyst Research & Price Targets - The Globe and Mail

Earnings Estimates

	Current Qtr03/2026	Next Qtr06/2026	Fiscal Yr12/2026	Fiscal Yr12/2027
Average Estimate	$-0.17	$-0.03	$0.09	$0.24
Number of Estimates	2	2	3	3
High Estimate	$-0.11	$-0.02	$0.28	$0.38
Low Estimate	$-0.22	$-0.03	$-0.07	$0.12
Prior Year	$-0.02	$0.12	$0.35	$0.09
Growth Rate Est. (year over year)	-750.00%	-125.00%	-74.29%	+166.67%

Earnings History - Surprises*

	Qtr Ending12/2025	Qtr Ending09/2025	Qtr Ending06/2025	Qtr Ending03/2025
Reported	$0.10	$0.11	$0.12	$-0.02
Estimate	$0.27	$0.12	$0.04	$-0.04
Difference	-0.17	-0.01	+0.08	+0.02
Surprise	-62.96%	-8.33%	+200.00%	+50.00%

* Earnings are based on GAAP income from continuing operations.

Average Analyst Ratings

4.31

3 Mths Ago13

4.31

2 Mths Ago13

4.31

1 Mth Ago13

4.15

Current13

Ratings Values:

Strong Buy5

Moderate Buy4

Hold3

Moderate Sell2

Strong Sell1

Ratings Breakdown

	3 Mths Ago	2 Mths Ago	1 Mth Ago	Current
# of Analysts:	13	13	13	13
	8 1	8 1	8 1	8 1
Holds	4	4	4	3
				1

Key:

Strong Buy

Moderate Buy

Hold

Moderate Sell

Strong Sell

More from The Globe

Lululemon appoints long-time Nike executive Heidi O’Neill as new CEO

Bullish on Pembina Pipeline Corp.

How investors should digest the stock market’s ‘sugar high’

Market Factors: Top picks, sector review for income-heavy utilities sector

The most oversold and overbought stocks on the TSX

The highest-yielding stocks on the TSX, plus risk data

Barlow’s Research Roundup: These stocks are biggest winners from oil price volatility

It’s not just Allbirds - another meme-stock season is on the horizon, Vanda Research says